Adipose-derived mesenchymal stem cells promote the survival of fat grafts via crosstalk between the Nrf2 and TLR4 pathways

[1]  A. Nadeem,et al.  TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma. , 2016, The international journal of biochemistry & cell biology.

[2]  D. Guan,et al.  SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2 , 2016, Cell Research.

[3]  S. Chun,et al.  Advanced Properties of Urine Derived Stem Cells Compared to Adipose Tissue Derived Stem Cells in Terms of Cell Proliferation, Immune Modulation and Multi Differentiation , 2015, Journal of Korean medical science.

[4]  W. Cao,et al.  Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation , 2015, Molecular and Cellular Biology.

[5]  M. Klinger,et al.  Response to “Autologous Fat Grafting: In Search of the Optimal Technique” , 2015, Surgical innovation.

[6]  S. Rocha,et al.  The role of hypoxia in inflammatory disease (Review) , 2015, International journal of molecular medicine.

[7]  Jing Huang,et al.  Adoptive Transfer of Heme Oxygenase-1 (HO-1)-Modified Macrophages Rescues the Nuclear Factor Erythroid 2-Related Factor (Nrf2) Antiinflammatory Phenotype in Liver Ischemia/Reperfusion Injury , 2014, Molecular medicine.

[8]  J. Klatt,et al.  Comment on “Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis” , 2014, The Annals of pharmacotherapy.

[9]  P. Romeo,et al.  Keap1‐Nrf2 system regulates cell fate determination of hematopoietic stem cells , 2014, Genes to cells : devoted to molecular & cellular mechanisms.

[10]  M. Ishihara,et al.  Low Oxygen Tension Enhances Proliferation and Maintains Stemness of Adipose Tissue–Derived Stromal Cells , 2013, BioResearch open access.

[11]  G. Pajardi,et al.  Fat Grafting Versus Adipose-Derived Stem Cell Therapy: Distinguishing Indications, Techniques, and Outcomes , 2013, Aesthetic Plastic Surgery.

[12]  D. Harrison,et al.  Murine Adipose Tissue-Derived Stromal Cell Apoptosis and Susceptibility to Oxidative Stress In Vitro Are Regulated by Genetic Background , 2013, PloS one.

[13]  Lorenzo Deveza,et al.  Paracrine release from nonviral engineered adipose-derived stem cells promotes endothelial cell survival and migration in vitro. , 2013, Stem cells and development.

[14]  A. Modarressi.  Platlet Rich Plasma (PRP) Improves Fat Grafting Outcomes , 2013, World journal of plastic surgery.

[15]  D. Sosnowska,et al.  Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  A. Jahanian-Najafabadi,et al.  Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity , 2012, Cell Stress and Chaperones.

[17]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[18]  H. Erdjument-Bromage,et al.  TLR signaling augments macrophage bactericidal activity through mitochondrial ROS , 2011, Nature.

[19]  J. Kim,et al.  The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells. , 2011, Stem cells and development.

[20]  Hyung-Min Chung,et al.  The pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration , 2010, Expert opinion on biological therapy.

[21]  S. Biswal,et al.  NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice , 2010, The Journal of Immunology.

[22]  DelindaA . Johnson,et al.  Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  C. Won,et al.  Responses of adipose-derived stem cells during hypoxia: enhanced skin-regenerative potential , 2009, Expert opinion on biological therapy.

[24]  R. Krams,et al.  Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  S. Reddy,et al.  Innate Immunity against Bacterial Infection following Hyperoxia Exposure Is Impaired in NRF2-Deficient Mice1 , 2009, The Journal of Immunology.

[26]  C. Weber,et al.  NADPH Oxidase Nox2 Is Required for Hypoxia-Induced Mobilization of Endothelial Progenitor Cells , 2009, Circulation research.

[27]  B. Lévy,et al.  Preconditioning by Mitochondrial Reactive Oxygen Species Improves the Proangiogenic Potential of Adipose-Derived Cells–Based Therapy , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Won-Serk Kim,et al.  Hypoxia‐enhanced wound‐healing function of adipose‐derived stem cells: Increase in stem cell proliferation and up‐regulation of VEGF and bFGF , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[29]  L. Poellinger,et al.  HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells. , 2009, Antioxidants & redox signaling.

[30]  R. Brandes,et al.  Nox4 Acts as a Switch Between Differentiation and Proliferation in Preadipocytes , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Ushio-Fukai,et al.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. , 2008, Cancer letters.

[32]  T. Afonyushkin,et al.  Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo , 2008, Circulation research.

[33]  K. Krause,et al.  NOX enzymes as novel targets for drug development , 2008, Seminars in Immunopathology.

[34]  P. Bugnon,et al.  Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance , 2008, The EMBO journal.

[35]  M. Ripoli,et al.  Role of reactive oxygen species as signal molecules in the pre-commitment phase of adult stem cells. , 2007, The Italian journal of biochemistry.

[36]  W. Aird,et al.  NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways* , 2007, Journal of Biological Chemistry.

[37]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[38]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[39]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[40]  E. Kızılkaya,et al.  The Role of Recipient Sites in Fat-Graft Survival: Experimental Study , 2005, Annals of plastic surgery.

[41]  DelindaA . Johnson,et al.  Nrf2, a multi‐organ protector? , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  J. Lambeth.  NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.

[43]  T. Galeotti,et al.  Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR* , 2002, The Journal of Biological Chemistry.

[44]  K. Messmer,et al.  Revascularization of Transplanted Adipose Tissue: A Study in the Dorsal Skinfold Chamber of Hamsters , 2002, Annals of plastic surgery.

[45]  P. Pölönen,et al.  Role of the Keap1-Nrf2 pathway in cancer. , 2014, Advances in cancer research.

[46]  Shizuo Akira,et al.  Signaling to NF-kappaB by Toll-like receptors. , 2007, Trends in molecular medicine.